Conduct Bioequivalence Study: CDSCO panel tells Abbott India on Dydrogesterone MR Tablets Dr. Divya Colin6 Aug 2023 6:00 PM ISTNew Delhi: Responding to the proposal for manufacturing and marketing synthetic progesterone, Dydrogesterone Modified-release (MR) Tablets presented...
Monitor endometrioma size of participants: CDSCO panel tells Abbott India on Dydrogesterone Isra Zaman14 Jun 2023 2:29 PM ISTSuggesting monitoring the size of the endometrioma of participating subjects during the clinical trial, the Subject Expert Committee (SEC) functional...
Monitor endometrioma size of clinical trial participants: CDSCO panel tells Abbott India on Dydrogesterone Dr. Divya Colin12 Jun 2023 6:00 PM ISTNew Delhi: Suggesting monitoring the size of the endometrioma of participating subjects during the clinical trial, the Subject Expert Committee (SEC)...
Zydus Healthcare Gets CDSCO Panel To Study Dydrogesterone Extended-release Tablets Dr. Divya Colin6 May 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Zydus...
Zydus Healthcare gets CDSCO panel nod to study Dydrogesterone film coated Sustained Release Tablets Dr. Divya Colin17 Feb 2023 6:00 PM ISTNew Delhi: Suggesting to monitor the size of endometrioma during the study, the Subject Expert Committee (SEC) functional under the Central Drug...
Oral Micronized Progesterone Carries Higher Risk of Miscarriage, shows Meta-Analysis Dr. Kamal Kant Kohli28 March 2022 12:10 PM ISTOral micronized progesterone carries the highest risk of miscarriage compared to oral dydrogesterone (DYD) and vaginal progesterone for the treatment...
Abbott gets CDSCO panel nod for importing, marketing of Estradiol, Dydrogesterone FDC Medical Dialogues Team11 July 2021 10:30 AM ISTNew Delhi: Approving Phase III Clinical Trial (CT) waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
